111 related articles for article (PubMed ID: 37878223)
1. Architecture and topologies of gene regulatory networks associated with breast cancer, adjacent normal, and normal tissues.
Kumar S; Vindal V
Funct Integr Genomics; 2023 Oct; 23(4):324. PubMed ID: 37878223
[TBL] [Abstract][Full Text] [Related]
2. Gene expression analysis of invasive breast carcinoma yields differential patterns in luminal subtypes of breast cancer.
Abdelhafiz AS; Fouda MA; Elzefzafy NA; Taha II; Mohemmed OM; Alieldin NH; Toony I; Abdel Wahab AA; Farahat IG
Ann Diagn Pathol; 2021 Dec; 55():151814. PubMed ID: 34517157
[TBL] [Abstract][Full Text] [Related]
3. Investigation of genes and pathways involved in breast cancer subtypes through gene expression meta-analysis.
Jafarinejad-Farsangi S; Moazzam-Jazi M; Naderi Ghale-Noie Z; Askari N; Miri Karam Z; Mollazadeh S; Hadizadeh M
Gene; 2022 May; 821():146328. PubMed ID: 35181505
[TBL] [Abstract][Full Text] [Related]
4. Identification of key genes unique to the luminal a and basal-like breast cancer subtypes via bioinformatic analysis.
Jia R; Li Z; Liang W; Ji Y; Weng Y; Liang Y; Ning P
World J Surg Oncol; 2020 Oct; 18(1):268. PubMed ID: 33066779
[TBL] [Abstract][Full Text] [Related]
5. Subtype-specific network organization of molecular complexes in breast cancer.
Kumar S; Ramaswamy R; Vindal V; Srivastava A
J Biosci; 2023; 48():. PubMed ID: 37493170
[TBL] [Abstract][Full Text] [Related]
6. Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery.
Kao J; Salari K; Bocanegra M; Choi YL; Girard L; Gandhi J; Kwei KA; Hernandez-Boussard T; Wang P; Gazdar AF; Minna JD; Pollack JR
PLoS One; 2009 Jul; 4(7):e6146. PubMed ID: 19582160
[TBL] [Abstract][Full Text] [Related]
7. Transcriptomics-based screening of molecular signatures associated with patients overall survival and their key regulators in subtypes of breast cancer.
Eskandari E; Motalebzadeh J
Cancer Genet; 2019 Nov; 239():62-74. PubMed ID: 31569063
[TBL] [Abstract][Full Text] [Related]
8. Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast Cancer.
Cejalvo JM; Martínez de Dueñas E; Galván P; García-Recio S; Burgués Gasión O; Paré L; Antolín S; Martinello R; Blancas I; Adamo B; Guerrero-Zotano Á; Muñoz M; Nucíforo P; Vidal M; Pérez RM; Chacón López-Muniz JI; Caballero R; Peg V; Carrasco E; Rojo F; Perou CM; Cortés J; Adamo V; Albanell J; Gomis RR; Lluch A; Prat A
Cancer Res; 2017 May; 77(9):2213-2221. PubMed ID: 28249905
[TBL] [Abstract][Full Text] [Related]
9. Analysis of tumor environmental response and oncogenic pathway activation identifies distinct basal and luminal features in HER2-related breast tumor subtypes.
Gatza ML; Kung HN; Blackwell KL; Dewhirst MW; Marks JR; Chi JT
Breast Cancer Res; 2011 Jun; 13(3):R62. PubMed ID: 21672245
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of DRAIC and TP53TG1 in breast cancer luminal subtypes through the construction of lncRNAs regulatory model.
Motalebzadeh J; Eskandari E
Breast Cancer; 2022 Nov; 29(6):1050-1066. PubMed ID: 35871431
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional Network Architecture of Breast Cancer Molecular Subtypes.
de Anda-Jáuregui G; Velázquez-Caldelas TE; Espinal-Enríquez J; Hernández-Lemus E
Front Physiol; 2016; 7():568. PubMed ID: 27920729
[TBL] [Abstract][Full Text] [Related]
12. An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells.
Holm K; Staaf J; Lauss M; Aine M; Lindgren D; Bendahl PO; Vallon-Christersson J; Barkardottir RB; Höglund M; Borg Å; Jönsson G; Ringnér M
Breast Cancer Res; 2016 Feb; 18(1):27. PubMed ID: 26923702
[TBL] [Abstract][Full Text] [Related]
13. Systems biology comprehensive analysis on breast cancer for identification of key gene modules and genes associated with TNM-based clinical stages.
Amjad E; Asnaashari S; Sokouti B; Dastmalchi S
Sci Rep; 2020 Jul; 10(1):10816. PubMed ID: 32616754
[TBL] [Abstract][Full Text] [Related]
14. Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis.
Thorat MA; Marchio C; Morimiya A; Savage K; Nakshatri H; Reis-Filho JS; Badve S
J Clin Pathol; 2008 Mar; 61(3):327-32. PubMed ID: 18037662
[TBL] [Abstract][Full Text] [Related]
15. PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers.
Bastien RR; Rodríguez-Lescure Á; Ebbert MT; Prat A; Munárriz B; Rowe L; Miller P; Ruiz-Borrego M; Anderson D; Lyons B; Álvarez I; Dowell T; Wall D; Seguí MÁ; Barley L; Boucher KM; Alba E; Pappas L; Davis CA; Aranda I; Fauron C; Stijleman IJ; Palacios J; Antón A; Carrasco E; Caballero R; Ellis MJ; Nielsen TO; Perou CM; Astill M; Bernard PS; Martín M
BMC Med Genomics; 2012 Oct; 5():44. PubMed ID: 23035882
[TBL] [Abstract][Full Text] [Related]
16. The gene expression landscape of breast cancer is shaped by tumor protein p53 status and epithelial-mesenchymal transition.
Fredlund E; Staaf J; Rantala JK; Kallioniemi O; Borg A; Ringnér M
Breast Cancer Res; 2012 Jul; 14(4):R113. PubMed ID: 22839103
[TBL] [Abstract][Full Text] [Related]
17. Tumor intrinsic subtype is reflected in cancer-adjacent tissue.
Casbas-Hernandez P; Sun X; Roman-Perez E; D'Arcy M; Sandhu R; Hishida A; McNaughton KK; Yang XR; Makowski L; Sherman ME; Figueroa JD; Troester MA
Cancer Epidemiol Biomarkers Prev; 2015 Feb; 24(2):406-14. PubMed ID: 25465802
[TBL] [Abstract][Full Text] [Related]
18. Combined analysis of receptor expression reflects inter-and intra-tumor heterogeneity in HR+/HER2+ breast cancer.
Ju J; Du F; Gao SL; Si YR; Hu NL; Liu DX; Wang X; Yue J; Zheng FC; Kang YK; Yang ZX; Ma F; Xu BH; Yuan P
Breast Cancer Res Treat; 2022 Jul; 194(2):221-230. PubMed ID: 35699854
[TBL] [Abstract][Full Text] [Related]
19. NRF1 motif sequence-enriched genes involved in ER/PR -ve HER2 +ve breast cancer signaling pathways.
Ramos J; Das J; Felty Q; Yoo C; Poppiti R; Murrell D; Foster PJ; Roy D
Breast Cancer Res Treat; 2018 Nov; 172(2):469-485. PubMed ID: 30128822
[TBL] [Abstract][Full Text] [Related]
20. Association of high obesity with PAM50 breast cancer intrinsic subtypes and gene expression.
Kwan ML; Kroenke CH; Sweeney C; Bernard PS; Weltzien EK; Castillo A; Factor RE; Maxfield KS; Stijleman IJ; Kushi LH; Quesenberry CP; Habel LA; Caan BJ
BMC Cancer; 2015 Apr; 15():278. PubMed ID: 25884832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
